1. National Institute of Diabetes and Digestive and Kidssney Diseases. Healthy people 2010: chronic kidney disease 2000. Bethesda ( MD ): National Institutes of Health, 2000.
2. Besarab A. Physiological and pharmacodynamic considerations for route of EPO administration. Semin Nephrol 2000; 20: 364–74.
3. Jones CA, McQuillan G, Kusek J. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey [published erratum appears in Am J Kidney Dis 2000;35:178]. Am JKidney Dis 1998; 32: 992–9.
4. Nissenson AR, Pereira BJ, Collins AJ, Steinberg EP. Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis 2001; 37: 1177–83.
5. Eckardt KU. Pathophysiology of renal anemia. Clin Nephrol 2000; 53: S2–8.